Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics

被引：151

作者：

Solga, SF ^{[1
]}

Diehl, AM ^{[1
]}

机构：

[1] Johns Hopkins Univ, Div Gastroenterol, Baltimore, MD 21205 USA

来源：

JOURNAL OF HEPATOLOGY | 2003年 / 38卷 / 05期

关键词：

D O I：

10.1016/S0168-8278(03)00097-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：681 / 687

页数：7

共 78 条

[1] Betaine for the treatment of nonalcoholic steatohepatitis: A promising new agent. [J].

Abdelmalek, MF ;

Angulo, P ;

Jorgensen, RA ;

Sylvestre, PB ;

Lindor, KD .

GASTROENTEROLOGY, 2000, 118 (04) :A973-A973

[2] ANTIBIOTICS PREVENT LIVER-INJURY IN RATS FOLLOWING LONG-TERM EXPOSURE TO ETHANOL [J].

ADACHI, Y ;

MOORE, LE ;

BRADFORD, BU ;

GAO, WS ;

THURMAN, RG .

GASTROENTEROLOGY, 1995, 108 (01) :218-224

[3] Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model [J].

Adawi, D ;

Ahrné, S ;

Molin, G .

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2001, 70 (03) :213-220

[4] Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat [J].

Adawi, D ;

Kasravi, FB ;

Molin, G ;

Jeppsson, B .

HEPATOLOGY, 1997, 25 (03) :642-647

[5] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].

Angulo, P ;

Keach, JC ;

Batts, KP ;

Lindor, KD .

HEPATOLOGY, 1999, 30 (06) :1356-1362

[6] Treatment of nonalcoholic fatty liver: Present and emerging therapies [J].

Angulo, P ;

Lindor, KD .

SEMINARS IN LIVER DISEASE, 2001, 21 (01) :81-88

[7] A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis [J].

Basaranoglu, M ;

Acbay, O ;

Sonsuz, A .

JOURNAL OF HEPATOLOGY, 1999, 31 (02) :384-384

[8] Prevalence of and risk factors for hepatic steatosis in northern Italy [J].

Bellentani, S ;

Saccoccio, G ;

Masutti, F ;

Crocè, LS ;

Brandi, G ;

Sasso, F ;

Cristanini, G ;

Tiribelli, C .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117

[9]

Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x

[10] Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].

Caldwell, SH ;

Oelsner, DH ;

Iezzoni, JC ;

Hespenheide, EE ;

Battle, EH ;

Driscoll, CJ .

HEPATOLOGY, 1999, 29 (03) :664-669

← 1 2 3 4 5 6 7 8 →